机械敏感离子通道Piezo1介导的Rap1-PI3K/AKT信号激活在强直性脊柱炎异位新骨形成中的作用机制研究
批准号:
81972039
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
刘辉
依托单位:
学科分类:
运动系统免疫相关疾病
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
刘辉
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
脊柱异位成骨是强直性脊柱炎(AS)致残的重要原因,目前无有效治疗方法。机械应力刺激是异位新骨形成的关键因素,但机制尚不清楚。机械应力敏感离子通道Piezo1在多种炎症性疾病中起重要作用。我们预实验发现,Piezo1在AS韧带标本中高表达;炎症因子可以上调成骨细胞Piezo1的表达;抑制Piezo1可以抑制应力刺激下的成骨分化,且需要Rap1-PI3K/AKT的参与;动物模型中,抑制Piezo1可以显著减轻异位新骨新成。由此我们提出科学假设:在附着点区域,炎症因子通过上调Piezo1表达与其介导的Rap1-PI3K/AKT信号活性,增强成骨前体细胞对应力刺激的应答,促进异位新骨形成。本课题拟在细胞模型中探讨炎症因子上调Piezo1及其促进成骨分化的分子机制,并在动物模型中验证Piezo1在异位新骨形成过程中的作用。本研究有望揭示AS异位成骨的新机制,为其防治提供新的靶点。
英文摘要
Axial skeleton ankylosis resulted from ectopic bone formation is a major cause of disability in patients with Ankylosing Spondylitis (AS). No targeted and effective therapy is available to prevent ankylosis progression in clinical practice so far. Previous studies have shown that mechanical force plays a critical role in ectopic new bone formation at the entheses. However, the detailed mechanism is not clear. Piezo1 is a newly identified mechanically activated ion channel with significant function in inflammatory diseases, but its effects on ectopic bone formation are not clarified. In our preliminary study, we discovered that Piezo1 was highly expressed in the bone forming sites of ligament tissues collected from AS patients. In a cell culture system, piezo1 was up-regulated by inflammatory cytokines in osteoprogenitor cells. Inhibition of piezo1 suppressed osteogenesis under mechanical stimulation in vitro and in vivo, which possibly through Rap1-PI3K/AKT pathway. Hence, we hypothesize that during ectopic new bone formation, inflammatory cytokines enhance the response of osteoprogenitor cells to mechanical force by up-regulation of Piezo1, therefore enhance bone formation via Rap1-PI3K/AKT signaling pathway. To prove this hypothesis, we propose the current study, including in vitro study for investigating the molecular mechanism of Piezo1- Rap1-PI3K/AKT axis enhancing new bone formation, as well in vivo study for validating its role in ankylosis. The potential findings would provide more insight of AS and help with identification of novel treatment strategies.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
BRD4 promotes heterotopic ossification through upregulation of LncRNA MANCR.
BRD4 通过上调 LncRNA MANCR 促进异位骨化。
DOI:10.1302/2046-3758.1010.bjr-2020-0454.r1
发表时间:2021-10
期刊:Bone & joint research
影响因子:4.6
作者:Liu L;Li Z;Chen S;Cui H;Li X;Dai G;Zhong F;Hao W;Zhang K;Liu H
通讯作者:Liu H
Aberrant upregulation of CaSR promotes pathological new bone formation in ankylosing spondylitis.
CaSR 的异常上调促进强直性脊柱炎病理性新骨形成
DOI:10.15252/emmm.202012109
发表时间:2020-12-07
期刊:EMBO molecular medicine
影响因子:11.1
作者:Li X;Chen S;Hu Z;Chen D;Wang J;Li Z;Li Z;Cui H;Dai G;Liu L;Wang H;Zhang K;Zheng Z;Zhan Z;Liu H
通讯作者:Liu H
Tenascin-C-mediated suppression of extracellular matrix adhesion force promotes entheseal new bone formation through activation of Hippo signalling in ankylosing spondylitis.
Tenascin-C 介导的细胞外基质粘附力抑制通过激活强直性脊柱炎中的 Hippo 信号促进附着点新骨形成
DOI:10.1136/annrheumdis-2021-220002
发表时间:2021-07
期刊:Annals of the rheumatic diseases
影响因子:27.4
作者:Li Z;Chen S;Cui H;Li X;Chen D;Hao W;Wang J;Li Z;Zheng Z;Zhang Z;Liu H
通讯作者:Liu H
DOI:10.1126/sciadv.abl8054
发表时间:2022-04-08
期刊:Science advances
影响因子:13.6
作者:Cui H;Li Z;Chen S;Li X;Chen D;Wang J;Li Z;Hao W;Zhong F;Zhang K;Zheng Z;Zhan Z;Liu H
通讯作者:Liu H
DOI:10.1136/ard-2022-223428
发表时间:2022-12-21
期刊:ANNALS OF THE RHEUMATIC DISEASES
影响因子:27.4
作者:Chen, Siwen;Li, Zihao;Liu, Hui
通讯作者:Liu, Hui
LIF介导的脂解与LDL/LPA/LPAR1信号激活在强直性脊柱炎病理新骨形成中的作用及机制研究
- 批准号:82372370
- 项目类别:面上项目
- 资助金额:49万元
- 批准年份:2023
- 负责人:刘辉
- 依托单位:
强直性脊柱炎病理新骨形成机制探索:干细胞来源及成骨分化调控
- 批准号:--
- 项目类别:省市级项目
- 资助金额:100.0万元
- 批准年份:2021
- 负责人:刘辉
- 依托单位:
LncRNA MIR22HG编码新多肽促进强直性脊柱炎异位新骨形成的机制研究
- 批准号:82172384
- 项目类别:面上项目
- 资助金额:55万元
- 批准年份:2021
- 负责人:刘辉
- 依托单位:
Wnt4/Fzd10/LRP6-NLK信号轴调控炎症微环境促进强直性脊柱炎异位成骨的机制研究
- 批准号:81772307
- 项目类别:面上项目
- 资助金额:55.0万元
- 批准年份:2017
- 负责人:刘辉
- 依托单位:
TNF-α诱导的Wnt/PKCδ信号激活在强直性脊柱炎异位新骨形成中的作用机制研究
- 批准号:81572103
- 项目类别:面上项目
- 资助金额:57.0万元
- 批准年份:2015
- 负责人:刘辉
- 依托单位:
LIM矿化蛋白-1抑制人椎间盘髓核细胞TNF-α的表达及其分子机制研究
- 批准号:81101384
- 项目类别:青年科学基金项目
- 资助金额:23.0万元
- 批准年份:2011
- 负责人:刘辉
- 依托单位:
国内基金
海外基金















{{item.name}}会员


